People with scleroderma (SSc) in Spain have a 1.5 times higher overall risk of cancer than the general population, according to a new study. Further, these patients were found to have a higher rate of lung, breast, and blood cancers. The risk of cancer is higher in patients with…
Horizon Therapeutics has launched its #RAREis Representation program aimed at increasing diversity, equity, and inclusion among patients with rare diseases. There are about 400 million people worldwide living with a rare disease; for many of them, access to diagnosis, care, and treatments can be challenging. Accessing better care depends on…
Oral treatment with C21 restored hand temperature by improving blood flow  in people with Raynaud’s phenomenon secondary to scleroderma, top-line data from a Phase 2 clinical trial show. “The results of the phase II study show that C21 can directly increase blood flow in fibrotic tissue,” Carl-Johan Dalsgaard,…
Having lung involvement increases the risk of in-hospital mortality, the length of hospital stays, and the costs related to hospitalization in people with scleroderma, a study of U.S.-based data finds. The study, “Lung involvement in systemic sclerosis is associated with adverse hospital outcomes: insights from the…
Get regular updates to your inbox.